Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group

Fingolimod is the first oral treatment of multiple sclerosis. It is the first-in-class sphingosine 1-phosphate receptor modulator that binds to sphingosine 1-phophate receptors on lymphocytes and via downregulation of the receptor prevents lymphocyte egress from lymphoid tissues into the circulation...

Descripción completa

Detalles Bibliográficos
Autor principal: Fazekas, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438392/
https://www.ncbi.nlm.nih.gov/pubmed/22895849
http://dx.doi.org/10.1007/s10354-012-0123-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438392/
https://www.ncbi.nlm.nih.gov/pubmed/22895849
http://dx.doi.org/10.1007/s10354-012-0123-y

Ejemplares similares